Walgreens Boots Alliance, Inc. (NASDAQ:WBA) shares edged slightly higher on Tuesday. The firm’s specialty pharmacy arm ...

Walgreens Specialty Pharmacy has expanded its limited distribution drug (LDD) network to now include 265 products, placing it ...

The biosimilar will be available to any licensed specialty pharmacy in the United States at a 95% discount from Stelara, starting January 1, 2026.

Walgreens Specialty Pharmacy, which earned $25.9 billion last year from U.S. prescription revenue, has expanded its limited distribution drug portfolio to 265 medications, the company said Aug. 19. ...

WATERTOWN, New York (WWNY) - A former bank location in Watertown is set to become a specialty pharmacy. According to city ...

Healthcare services provider BrightSpring Health Services (NASDAQ:BTSG) reported Q2 CY2025 results exceeding the market’s ...

Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a pharmacy partner by Jazz ...

Pharmacy leaders at health systems across the country say preserving the intent of the federal 340B drug pricing program and increasing transparency around pharmacy benefit managers are the most ...

Kite Pharma is acquiring Interius BioTherapeutics for $350 million, adding in vivo CAR T technology that could simplify treatment and expand patient access.

MedImpact Holdings is planning to offer an unbranded biosimilar ustekinumab-aekn at a significantly lower cost than Stelara. The biosimilar, distributed by Anda, an affiliate of Teva Pharmaceuticals ...